AUGX earnings

SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024. On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference call. About Augmedix Augmedix (NASDAQ:AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and

SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024. "Augmedix delivered in-line first quarter performance, with 40% revenue growth, 143% net revenue retention and 47.1% gross margins," commented Manny Krakaris, Augmedix CEO. "We are confident about our positioning within the medical documentation market, and expect to report continued growth throughout the rest of the year. It is now clear, however, that health systems are proceeding methodically while they develop a better understanding of the capabilities of AI products." "We a

SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1666696&tp_key=f217dd82fa An archived replay will be available following the call on Augmedix's IR website at https://ir.augmedix.com/. About Augmedix Augmedix (NASDAQ:AUGX) empowers clinicians to conn

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three and 12 months ended December 31, 2023. "The fourth quarter was a solid end to a strong year for Augmedix both operationally and financially," stated Augmedix CEO Manny Krakaris. "We delivered a 45% increase in revenue to $12.7 million, ahead of our most recent guidance, driven by a 44% increase in clinicians in service and net revenue retention of 152%. Additionally, we made steady progress toward our profitability goals by increasing gross profit by 54% to $6.2 million, a margin expansion of 300 basis poi

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024. Following the release, management will host a conference call and audio webcast to review results and provide a brief business and outlook update that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1656407&tp_key=3507378dc0 An archived replay will be

SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced preliminary revenue results and operational metrics for the fourth quarter of 2023. "Augmedix's expected fourth quarter revenue of approximately $12.5 million puts us on pace to deliver a solid finish to a strong year," stated Augmedix CEO Manny Krakaris. "We enter 2024 with approximately $51 million in expected Annual Recurring Revenue, driven by strong adoption of Augmedix Live and Augmedix Notes by our health system customers. With Augmedix Go now generally available in the ambulat

SAN FRANCISCO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, reported today financial results for the three and nine months ended September 30, 2023. "The third quarter marked another period of strong progress for Augmedix as we continue to be a leader in the large and rapidly growing ambient medical documentation market," commented Manny Krakaris, Chief Executive Officer at Augmedix. "Growing adoption of Augmedix Live and Augmedix Notes drove 50% revenue growth and net revenue retention of 157%, while expanding gross margins by 390 basis points to 49.5%. With stron

SAN FRANCISCO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will report financial results for the third quarter ended September 30, 2023, on Monday, November 6, 2023, after the market closes. Management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the conference call will be available on the "Events" section of the Company's website at: https://ir.augmedix.com/news-events. Alternatively, interested parties can dial 877-407-3982 (toll-free) or 201-493-6780 (international) to listen. The we

SAN FRANCISCO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and six months ended June 30, 2023. "This was another strong quarter for Augmedix, as we continue to solidify our position within the burgeoning ambient medical documentation market," commented Manny Krakaris, Chief Executive Officer at Augmedix. "We set records for revenue, growing 47% year-over-year, and dollar-based net revenue retention at 148%, demonstrating that healt

SAN FRANCISCO, July 28, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced it will report financial results for the second quarter ended June 30, 2023, on Monday, August 7, 2023, after the market closes. Company management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the conference call will be available on the "Events" section of the Company's website at: https://ir.augmedix.com/news-events. Alternatively, interested p

SAN FRANCISCO, May 12, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three months ended March 31, 2023. "Augmedix begins 2023 with continued commercial momentum, increasing operating leverage, and a landmark strategic partnership and financing with HCA Healthcare, Inc., one of the nation's leading healthcare providers," commented Manny Krakaris, Chief Executive Officer at Augmedix. "Together with HCA Healthcare, we are accelerating the development of

SAN FRANCISCO, May 08, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (NASDAQ:AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced it will report financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023, before the market opens. Company management will host a conference call that day at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the conference call will be available on the "Events" section of the Company's website at: https://ir.augmedix.com/news-events. Alternatively, interested parties can dial 87

Company raises $12 million of new equity from HCA Healthcare and Redmile Group;Augmedix and HCA Healthcare to collaborate on AI-powered ambient documentation products for the acute care setting;Provides sufficient capital to achieve cash flow sustainability SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (NASDAQ:AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced that it has executed a strategic financing with HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, and Redmile Group, LLC, a San

SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leading provider of ambient medical documentation and data solutions delivered remotely to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and 12 months ended December 31, 2022. "We finished 2022 with our best-ever fourth quarter in terms of bookings, with sales momentum continuing into 2023 with record first-quarter bookings, including our largest-ever clinician cohort signed," said Manny Krakaris, Chief Executive Officer at Augmedix. "Our expanding portfolio of products has positioned us well for the large market opportunity in fr

SAN FRANCISCO, March 16, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced it will report financial results for the fourth quarter and full-year ended December 31, 2022 on Monday, March 27, 2023, before the market opens. Company management will host a conference call that day at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time. Live audio of the conference call will be available on the "Events" section of the Company's website at: https://ir.augmedix.com/news-events. The webcast will be archived and available for replay after the event. Additionally, Manny

SAN FRANCISCO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced preliminary financial results and operational metrics for the fourth quarter of 2022. "Augmedix generated strong bookings in the fourth quarter and we expect revenue to be within our guidance range of $8.5 million to $8.6 million," stated Augmedix, Inc. CEO, Manny Krakaris. "Our current pipeline and backlog should result in continued momentum and a strong start to 2023. Importantly, we are seeing significant expansion within our base of existing clients. Over the last few months, we'v

SAN FRANCISCO, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended September 30, 2022. "We are pleased with our record third quarter as it serves as a testament to the market's accelerating adoption of our highly differentiated and broad product portfolio.  Our Ambient Automation Platform enables us to generate medical notes that are not only accurate and timely, but also incorporate clinician preferences, a feature greatly appreciated by our customers.  Moreover, our offerings continue to directly address the severe physician burnout a

SAN FRANCISCO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), an industry-leading provider of ambient medical documentation and data solutions, today announced it will report financial results for the third quarter of 2022 on Monday, November 14, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the conference call will be available on the "Events" section of the Company's website at: https://ir.augmedix.com/news-events. The webcast will be archived and available for replay after the event. About Augmedix Augmedix (NASDAQ:AUGX) delivers industry-leading, ambient medica

SAN FRANCISCO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended June 30, 2022. "This quarter, we continued to see good momentum and are pleased with our strong start to 2022. We remain focused on our path to profitability as we drive enterprise customer expansion, make good progress on our automation and new product development, and scale our business model. The operating leverage inherent in our business model helps us realize economic benefits as we grow the business. As a result, we now have over two years of operating runway based on cash

SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the second quarter of 2022 on Monday, August 8, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast DetailsThe conference call can be accessed by dialing +1-877-407-3982 for U.S. participants or +1-201-493-6780 for international participants and referencing conference ID # 13730853. Interested parties may access a live and archived webcast of the event on the "Events" section

SAN FRANCISCO, May 09, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended March 31, 2022. Manny Krakaris, Chief Executive Officer of Augmedix, commented, "We are pleased with our start to 2022 as we continue to make meaningful progress on several growth-focused initiatives, as well as extending our relationships with existing customers. Our main focus has been and will continue to be a path towards a completely automated note, and we have made great strides in this respect. We look forward to building upon the groundwork we have laid out to drive additio

SAN FRANCISCO, April 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the first quarter of 2022 on Monday, May 9, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast DetailsThe conference call can be accessed by dialing + 1-877-300-8521 for U.S. participants or +1 (412) 317-6026 for international participants and referencing conference ID # 10166440. Interested parties may access a live and archived webcast of the event on the "Events" section

SAN FRANCISCO, March 21, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended December 31, 2021. "We are pleased with the progress we made in 2021, as we continued to execute well across our strategic initiatives and finished the year by delivering our strongest quarter to date," said Manny Krakaris, Chief Executive Officer at Augmedix. "The fourth quarter was highlighted by our accelerated revenue growth, gross margin expansion, and meaningful progress along our path to a fully-automated medical note. Our highly differentiated approach to the medical note

SAN FRANCISCO, March 07, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the fourth quarter and full year 2021 on Monday, March 21, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast DetailsThe conference call can be accessed by dialing + 1-877-407-3982 for U.S. participants or +1 (201) 493-6780 for international participants and referencing conference ID # 13726968. Interested parties may access a live and archived webcast of the event on the "E

SAN FRANCISCO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leading provider of virtual medical documentation and live clinical support, today announced it will report financial results for the third quarter 2021 on Tuesday, November 9, 2021, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast DetailsThe conference call can be accessed by dialing +1 (877) 407-3982 for U.S. participants or +1 (201) 493-6780 for international participants and referencing conference ID #13723538. Interested parties may access a live and archived webcast of the event on the "Investor